After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, OGN falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Organon & Co is $2.67B. A total of 3.04 million shares were traded on the day, compared to an average of 4.03M shares.
In the most recent transaction, COX CARRIE SMITH bought 12,469 shares of OGN for 8.07 per share on May 14 ’25. After the transaction, the Director now owns 12,469 company shares. In a previous transaction on May 07 ’25, Falcione Aaron bought 5,500 shares at 8.77 per share. OGN shares that Chief Human Resources Officer owns now total 62,974.
Among the insiders who bought shares, Weaver Kirke acquired of 8,045 shares on May 06 ’25 at a per-share price of $9.21. This resulted in the Gen. Counsel & Corp. Secy. holding 52,489 shares of OGN after the transaction. In another insider transaction, Karp Daniel bought 3,500 shares at $8.24 per share on May 06 ’25. Company shares held by the Executive VP, Corp. Dev. now total 46,669.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Organon & Co pays an annual dividend of $0.60, resulting in a dividend yield of 5.85%, and it has a price to earnings (P/E) ratio of 3.81.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, OGN has a high of $21.06 and a low of $8.01.
As of this writing, OGN has an earnings estimate of $0.93 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.96 per share and a lower estimate of $0.89. The company reported an EPS of $0.87 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. OGN’s latest balance sheet shows that the firm has $737.00M in Cash & Short Term Investments as of fiscal 2021. There were $9.13B in debt and $2.60B in liabilities at the time. Its Book Value Per Share was $2.82, while its Total Shareholder’s Equity was -$1.51B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OGN is Buy with a score of 3.13.
